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Abstract Velopharyngeal insuYciency (VPI) is a struc-
tural or functional trouble, which causes hypernasal speech.
Velopharyngeal Xaps, speech therapy and augmentation
pharyngoplasty, using diVerent implants, have all been used
to address this trouble. We hereby present our results fol-
lowing rhinopharyngeal autologous fat injection in 18
patients with mild velopharyngeal insuYciency (12 soft
palate clefts, 4 functional VPI, 2 myopathy). 28 injections
were carried out between 2004 and 2007. The degree of
hypernasal speech was evaluated pre- and postoperatively
by a speech therapist and an ENT specialist and quantiWed
by an acoustic nasometry (Kay Elemetrics™). All patients
were exhaustively treated with preoperative speech therapy
(average, 8 years). The mean value of the nasalance score
was 37% preoperatively and 23% postoperatively
(p = 0.015). The hypernasality was reduced postoperatively
in all patients (1–3 degrees of the Borel-Maisonny score).
There were no major complications, two minor complica-
tions (one hematoma, one cervical pain). The autologous fat
injection is a simple, safe, minimally invasive procedure. It
proves to be eYcient in cases of mild velopharyngeal
insuYciency or after a suboptimal velopharyngoplasty.
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Introduction
Velopharyngeal closure is the result of the combined action
of the velar and pharyngeal muscles. Velopharyngeal
insuYciency (VPI) results in hypernasal speech and occa-
sionally in nasal regurgitation. This condition is most com-
monly the consequence of an anatomic abnormality: cleft
palate, submucous clefts, congenital short soft palate and
defects linked to over 400 recognized syndromes, with
velocardiofacial (VCF) being the most common [1]. Iatro-
genic causes are also common with an important incidence
of VPI after adenoidectomy or uvulopharyngopalatoplasty
(UPPP) in patients with occult submucous cleft palate or a
short velum. In most cases, VPI may be compensated by
reinforcement of the medial (Passavant’s pad) and lateral
pharyngeal wall by speech therapy and/or by the presence
of adenoid rests. A velopharyngoplasty is indicated when
the velar and pharyngeal contractions are deWcient and the
velopharyngeal space too large. In cases of minor VPI with
preserved velar motion, or after insuYcient results of a
velopharyngoplasty, an augmentation of the posterior pha-
ryngeal wall can be proposed. Since the Wrst description of
the augmentation pharyngoplasty with Vaseline in 1900 by
Gersuny [2], a large sample of diVerent materials has been
used: paraYn [3], teXon [4–6], silicone [7], collagen [8],
autologous cartilage [9], mucosal and muscle Xaps [10, 11].
In 1926, von Gaza [12] described the Wrst autologous fat
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an external cervical approach. In 2001, Dejonckere et al.
[13] injected autologous fat transorally in 17 patients with
mild VPI with good results in terms of nasality and patient
satisfaction with an average follow-up of 9 months. We
present our results of 28 autologous fat injections in the
posterior pharyngeal wall in 18 patients with speech and
acoustic nasometric long-term results.
Materials and methods
Patients: inclusion criteria
Eighteen patients were included in the study (13 female and
5 male), mainly adolescents, ages 8–53 years (average
19.6 years). All patients had a consistent hypernasal voice
during conversational speech as evaluated by an experi-
enced team composed of a phoniatrician and a speech ther-
apist. Patients were operated and followed in a single
institution (Department of Otolaryngology, Head and Neck
Surgery, University Hospital of Lausanne), between May
2004 and May 2008. Our inclusion criteria were (1) moder-
ate hypernasal speech without major articulatory VPI-
related troubles; (2) visible velar mobility allowing a velo-
pharyngeal closure of at least 50%, evaluated by nasoWb-
roscopy; (3) extensive speech therapy. Exclusion criteria
included contraindication for general anesthesia and severe
articulatory or language acquisition delay. The etiology of
the VPI was a short palate after correction of a cleft palate
for 12 patients, a short soft palate for 4 patients, and myop-
athy (myotonic dystrophy and chronic progressive external
ophthalmoplegia) for 2 other patients. Three patients were
known to have a VCF syndrome with cleft palate and facial
malformation. Six patients had been treated previously by a
velopharyngoplasty but still demonstrated nasal air emis-
sion during phonation. One patient had a previous retropha-
ryngeal autologous fat injection in another center with
inadequate results. All patients were extensively treated
with preoperative speech therapy (average 8 years).
Patients’ details are summarized in Table 1.
Pre and postoperative evaluations
The pre and postoperative assessments included: clinical
examination of the voice; nasoWbroscopy and instrumental
evaluation of the rhinolalia. The perceptual evaluation of
the voice was judged by a speech pathologist and a
phoniatrician using spontaneous speech, a short phoneti-
cally equilibrated text with nasal and denasal phonemes
Table 1 Description of patients
F Female, M male, CP cleft palate), CLP cleft labial palate, SP congenital short soft palate, MP myopathy), VPP velopharyngoplasty, Age age at
the Wrst injection, BM Borel-Maisonny score, Follow-up interval in months between the preoperative evaluation and the last intervention, 22q11
velo-cardio-facial syndrome
Patient Sex Age Cause of VPI Previous 
VPP
No injections Follow-up 
(months)
BM 
preop
BM 
postop
Nasalance 
preop (%)
Nasalance 
postop (%)
1 F 10 CP + 2 11 2m 2b 61 50
2 F 12 CP + 3 19 2 2/1 34 29
3 F 21 SP 3 22 2 2/1 50 24
4 F 11 CLP/22q11 2 12 2/1 1/2 17 7
5 F 16 CP 1 2 2/1 2/1 25 29
6 F 15 CLP 2 20 2b 1 16 5
7 F 53 MP 1 6 2 1/2 63 25
8 M 11 CP 2 12 2m 1/2 40 20
9 F 34 CLP 2 20 2/1 1/2 54 39
10 M 18 CP + 1 5 2m 2b 33 28
11 F 13 SP + 1 8 2b 1/2 30 12
12 M 13 CP/22q11 + 1 5 2/1 1/2 37 21
13 F 33 SP + 2 6 2b 1 28 11
14 M 8 SP 1 10 2/1 1 19 8
15 F 12 CP 1 8 2/1 1/2 31 10
16 F 43 MP 1 7 2b 2b 63 59
17 F 13 CP 1 6 2/1 1/2 19 20
18 M 17 CP/22q11 1 10 2b 2/1 44 23
Mean 19.6 1.6 10.5 37 23
Total 13F/5M 28123
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limit interjudge variability, the perceptive scores were rated
in consortium. The hypernasality was evaluated with the
Borel-Maisonny score, based on the audible nasal emission,
intelligibility and compensatory articulation during phona-
tion (Table 2) [14]. Patients with severe articulation disor-
ders (Borel-Maisonny score 3) were not included because
the abnormal compensatory articulation with loss of intelli-
gibility supplants the audible nasal air emission in the
social discomfort and because these articulatory disorders
could aVect our clinical evaluation. The nasoWbroscopy
(Rhino-Laryngo Fibrescope ENF-GP, Olympus © , Japan)
was performed under local anesthesia. The patient was
asked to produce the phonemes /a/, /i/, and /s/, which
enabled evaluation of velar mobility and the degree of velo-
pharyngeal closure. We evaluated the presence of a submu-
cosal cleft, adenoid rests, and compensatory signs
(Passavant’s pad, lateral pharyngeal wall contraction). Spe-
cial attention was given to identify an eventual ectopic
carotid with an aberrant course in the rhinopharynx. The
objective, quantitative assessment of nasalance was
obtained using a KayPENTAX Model 6200 Nasometer.
This technique consists of registering and Wltering sepa-
rately the acoustic energy emanating from the nose and the
mouth with a microphone. The computer expresses a ratio
of the nasal to nasal-plus-oral acoustic energy as a percent-
age called, nasalance [15]. The average nasalance value in
normal French speech is deWned as less than 30% for oral
phonemes. A routine assessment of nasalance was made
using the vowels /a/, /o/, /i/, four short French sentences
without nasal phonemes and a short French text of about
30-s reading time that contained no nasals. Each patient
was evaluated preoperatively and postoperatively at
2 weeks, 2 months, 6 months, and every year postopera-
tively. The decision for a recurrent fat injection was made
at the second postoperative evaluation (about 2 months
after the intervention). This decision was based Wrst on the
wishes and satisfaction of the patient, then on the percep-
tual evaluation of nasality and on the nasoWbroscopic eval-
uation of the fat pad in the rhinopharynx.
Surgical procedure
The procedures were executed under general anesthesia.
The ventilation tube passed through the mouth. The site of
fat harvesting was sterilely prepared (21 patients from the
medial knee, 4 patients from the Xank, 3 patients from the
abdominal wall). A 2-mm skin incision was achieved with-
out prior subcutaneous injection. When the patients had
undergone a previous lipoaspiration, we chose the opposite
leg or side of the abdomen. A 3-mm Coleman lipoaspira-
tion canula connected to a 10-ml sterilized Luer-lock
syringe was introduced and about 15 ml of fat tissue was
gently aspirated under negative pressure according to the
Coleman technique [16]. The syringe with aspirated fat was
then placed in a sterilized sleeve in a centrifuge and spun at
3,000 rpm for 3 min to separate the aspirate from the nonvi-
able components. The usable fat tissue, about 12 ml, was
isolated and prepared in a 1-ml sterilized Luer-lock syringe.
The pharynx was exposed such as in the classical tonsillec-
tomy procedure with the tongue and the ventilation tube
reclined with an orthostatic spatula (Fig. 1). A pediatric
Wberbronchoscope (BF-MP60, Olympus © ) was introduced
through the choana and the velum retraced upwards
enabling good visibility of the rhinopharynx. The prepared
fat was then injected intraorally in the submucosa of the
rhinopharynx with a slightly curved-in 20-gauge canula.
The main injection site was median at the point of velopha-
ryngeal closure during phonation. Several paramedian
injections were necessary to achieve a good pad of fat such
that a “neo-Passavant’s pad” was formed. The aim was to
narrow the nasopharyngeal passage optimally. We inten-
tionally avoided injecting too deeply forcing contact with
the vertebral ligament or too laterally in contact with the
tubar fossae. The postoperative course was simple: the
patients were able to speak and swallow as soon as they
recovered from the general anesthesia and were discharged
the same day. The patients received a prescription for a 5-
day prophylactic antibiotherapy (amoxicillin/clavulanic
acid, 3£ 625 mg, 500/125 per day. The Student’s t test was
used (with p < 0.001 considered as signiWcant) to compare
nasalance improvement pre and postoperatively, using
SPSS Statistics® 17.0.
Results
Twenty-eight fat injections were performed in the 18
patients, which represented a mean of 1.6 interventions per
Table 2 Borel-Maisonny Score [14]: subjective evaluation of the
hypernasality
Type 0 No phonation
Type 1 Excellent phonation, no nasal air emission
Type 1/2 Good phonation, intermittent nasal air emission, 
good intelligibility
Type 2/1 Phonation with partially corrected nasal air emission
Type 2b Phonation with continuous nasal emission 
but good intelligibility and no social discomfort
Type 2m Phonation with continuous nasal emission, 
poor intelligibility
Type 2/3 Phonation with continuous nasal emission 
with compensatory articulation, poor intelligibility
Type 3 Continuous compensatory articulation, 
bad intelligibility123
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dure was 6.1 months. The average clinical follow-up period
was 10.5 months (5–22 months) between the preoperative
and the last postoperative assessment. The medial knee was
chosen as the site of fat harvesting in most cases (21/28),
essentially for aesthetic and ease of access reasons. The
average volume of autologous injected fat was 11 ml. All
patients were asked about immediate and delayed postoper-
ative complications (hematoma, fever, infections) and pain.
Most patients described immediate postoperative discom-
fort or mild pain in the nape of the neck, which disappeared
the day after the intervention. One patient (No. 7) com-
plained of pain in the region of the nape of the neck up to
3 weeks after the procedure. The localization of the pain
could be explained by the operative position with hyperex-
tension of the head and probably also by irritation of the
vertebral ligament caused by the injections. One patient
(No. 10) presented a postoperative hematoma of the medial
knee, which did not necessitate any treatment. There were
no complaints concerning the scar from the fat-harvesting
incision. There were no major complications (e.g., bleed-
ing, infections, and embolism). The perceptual nasality
results (Borel-Maisonny score) are presented in Fig. 2 with
the pre and postoperative scores (after the last injection).
The nasality was signiWcantly improved in all patients
except Patient No. 16 (p < 0.001). Eleven patients had good
postoperative phonation and three patients had entirely
overcome their hypernasality. All patients had good intelli-
gibility postoperatively. The objective quantitative results
are presented in Fig. 3. The mean preoperative nasalance
score was 36.5 and 23.3% postoperatively, after the last
injection. The nasalance was signiWcantly improved in all
but two patients (Patients No. 5 and No. 16) (p < 0.001).
The criteria for a successful outcome were the satisfac-
tion of the patient and the reduction of the nasal air emis-
sion observed subjectively (Borel-Maisonny score) and
objectively (Nasometry). The necessity of recurrent inter-
vention was caused by signiWcant fat resorption causing a
reoccurrence of the hypernasal speech. Subjectively, all
patients but one (Patient No. 16) declared that they were
satisWed.
Fig. 1 Injection of autologous fat tissue in the submucosa of the pos-
terior wall of the rhinopharynx under Wbroscopic visualization. The
site of injection in the rhinopharynx is accessed intraorally
Fig. 2 The perceptive nasality results according to (the) Borel-Mai-
sonny score (Table 2). Postoperative scores are quoted after the last
injection
Fig. 3 The pre and postoperative nasalance results measured by Nas-
ometry (KayPENTAX™). Normal nasalance is deWned as less than or
equal to 30% for oral phonemes123
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remained stable. No fat tissue migration was observed. An
early resorption, between 30 and 50%, estimated with naso-
Wbroscopy, was observed at the Wrst postoperative evalua-
tion (2 months). At the following postoperative
assessments, the fat pad appeared to be persistent and sta-
ble. A fat pad was present and still visible up to 22 months
after the injection in one patient. Similarly, the functional
postoperative results were stable after the Wrst 2-month
period of resorption.
Discussion
The goals of VPI treatment are to restore adequate function
of the velopharyngeal sphincter, thereby diminishing nasal
air emission during phonation, and to improve a patient’s
ability to communicate. In case of mild VPI, speech therapy
plays an essential role but may be insuYcient if an ana-
tomic defect exists. Injections of diVerent substances in the
posterior pharyngeal wall to reduce the velopharyngeal
space have been described in the literature for about
100 years. Soft tissue augmentation with an injected Wller
has been widely used by laryngologists for vocal fold med-
ialization. Alloplastic materials are generally well tolerated
but may evoke a foreign-body giant cell reaction (poly-
dimethylsiloxane [17], teXon [18]), delayed hypersensitiv-
ity (collagen [19]) and injectate migration (teXon [20]).
Cartilage and mucosal Xaps have the advantage of avoiding
these reactions, but the graft harvesting may increase
patient’s morbidity. Autologous fat as a soft substance is
often considered as an ideal Wller. Furthermore, it appears
to be safe, nonimmunogenic, inexpensive, and is readily
obtainable with low donor site morbidity [21]. For all these
reasons, autologous fat transplantation has been broadly
used for soft tissue augmentation by plastic surgeons and
otolaryngologists for more than 100 years [22]. The major
disadvantage of autologous fat is that initial augmentation
may diminish rapidly due to fat resorption. This resorption
results from the necrosis of fat at the time of transfer and
gradual resorption of successfully transferred fat [23].
DiVerent modiWcations of the original techniques to address
fat viability have been described during the last decades.
The modiWcations essentially concern the donor site, the
aspiration methods, and the preparation and injection meth-
ods [24]. Despite the number of reports describing diVerent
harvest sites, there is no evidence of a preferred donor site
for fat viability [25]. The abdominal wall, Xank and medial
knee are the most common donor sites, essentially because
of the ease of access and aesthetics. Concerning the aspira-
tion methods, conventional liposuction using a high nega-
tive vacuum extraction technique have been reported to
damage up to 90% of the lipocytes [26]. Coleman proposed
limiting the vacuum to the minimal negative pressure, man-
ually withdrawing with a 10-ml syringe attached to a 3-mm
two-holed blunt canula in a gradual manner [16]. Others
have proposed a minimally traumatic technique, by which
the fat tissue is drilled out through a sharp 4.5-mm canula
[27]. Animal studies have suggested that direct excision
allows increased graft survival rates compared to lipoaspi-
ration [28, 29]. However, fat aspiration using the Coleman
technique is the most popular method, as reported in the lit-
erature. The preparation of the harvested fat is one of the
most essential conditions in terms of viability. Coleman
emphasized the importance of removing the nonviable
components of the aspirate (oil from ruptured lipocytes and
blood) by centrifugation at 3,000 rpm for 3 min to isolate
the viable lipocytes [16]. This technique has been widely
accepted and has widespread use. Marques et al. [29] found
a signiWcantly better survival rate by washing the aspirated
fat with Ringer’s solution. The washing is suggested to
eliminate inXammatory mediators and decrease resorption
at the host site. Another method for improving fat survival
and enhancing cell growth is the addition of growth factors
[30]. Many authors report not adding growth factors
because there are risks of chemical and mechanical damage
to the delicate fat tissue [16], and there is little clinical evi-
dence for use of such measures [24]. The site of injection is
particularly important knowing that fat graft survival is
principally based on the proximity to a blood supply. A dis-
tance of 2 mm from an arterial supply seems to be essential
for fat graft survival; beyond this distance the fat tissue will
necrose and Wbrose [31]. There is a lack of accurate results
concerning the fat graft survival in humans. Animal studies
have demonstrated survival depending on the transfer site
with the best longevity being when it is into the subcutane-
ous tissue [32]. Most clinical studies are based on subjec-
tive evaluations. Har-Shai et al. [33] report a fat graft
survival rate up to 90% at 24 months using an integrated
approach, and a pessimistic survival rate of 25% after
8 months [34]. We observed fat resorption between 30 and
50% at 2 months. The complications are rare and are the
same in other surgical procedures: infections, local bleed-
ing. Complications associated with the incision and har-
vesting (scars, bleeding) are rare. More dramatic
complications concerning facial injections, such as fat
emboli in the retinal and cerebral arteries, have been
reported sparsely in the literature [35].
In searching for the ideal Wller, the choice of autologous
fat must be balanced with the necessity of eventual re-inter-
ventions. However, a certain quantity of fat resorption rep-
resents the advantage of avoiding an over-correction of the
VPI, resulting in potential nasal obstruction, snoring and
discomfort. Furthermore, our patient group is young (aver-
age 19.6 years), and the long-term morbidity (inXamma-
tion, infection, migration, extrusion carcinogenicity) of123
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these reasons, we chose autologous fat as the injection
material for our patients.
The most important condition for a satisfactory result
after autologous fat injection in the rhinopharynx is judi-
cious selection criteria of the patients: Good velar mobility
and velopharyngeal closure better than 50%. The case of
Patient No. 16 illustrates the limits of this technique. This
patient suVers from progressive degenerating myopathy
(with chronic progressive external ophthalmoplegia). At the
time of the preoperative evaluation, the mobility of the
velum was still preserved, but particularly weak. Postopera-
tively, velopharyngeal closure was still insuYcient, and the
subjective and objective assessments did not demonstrate
any signiWcant improvement of the rhinolalia, despite a sat-
isfactory fat pad that was visible by nasoWbroscopy. For
this reason, we consider that the decision for autologous fat
injection in the rhinopharynx of patients suVering from
myopathy or degenerative motoneurone diseases should be
carefully made.
The three patients with cleft palate associated with a
VCF syndrome obtained excellent postoperative results and
were particularly satisWed. The autologous fat injection, as
a minor and outpatient procedure is well suited for young
patients who suVer from rhinolalia in their personal and
educational development.
Patient No. 5 improved her nasality postoperatively,
despite elevated nasalance. A possible explanation is that
the patient presented with slight nasal congestion during the
preoperative nasometric assessment, which could have
underestimated the nasalance. The fact remains that the
patient was satisWed with her intervention and her postoper-
ative phonation.
The site of the injection is essential to avoid potential
complications and to obtain satisfactory functional results.
First, the injections should be given directly into the sub-
mucosa, taking care not to inject too deeply. The submu-
cosa is safe, without vital structures, and contains leak
connective tissue allowing better compliance than the
deeper muscle layer. A deeper injection into the preverte-
bral muscle layer can be painful and runs the risk of carotid
injury or embolism with dramatic consequences. Special
attention should be paid during the preoperative nasoWbro-
scopic evaluation for identifying an ectopic carotid course.
Remacle et al. [8] indicated the principle site of injection to
be the median line and warned against injecting too later-
ally where the Wbrous tunic is less dense because larger
quantities are required to attain the same results. Fat resorp-
tion over time is an important factor that must be consid-
ered and an overinjection by approximately 30% is
advocated [36].
Nasal regurgitation is a possible complication after ade-
noidectomy or UPPP in case of submucous cleft palate or
short velum. In our patients, cohort velopharyngeal autolo-
gous fat injection has improved nasal regurgitation in one
patient with case of VPI after correction of a cleft soft pal-
ate (Patient 5). This patient had a light open rhinolalia (pre-
operative Borel-Masonny score 2/1, preoperative nasalance
25%) but was socially handicapped by a recurrent nasal
regurgitation with liquids. After the nasopharyngeal fat
injection, the regurgitations became exceptional and the
patient was satisWed. Velopharyngeal autologous fat injec-
tion may represent a complementary treatment to the velo-
pharyngeal reeducation in case of intermittent nasal
regurgitation.
It is interesting to note that seven patients (No. 3, 6, 7,
10, 11, 14, 15) had a tendency to improve their phonation
and diminish their nasalance value even long after the fat
injection. This can be explained by the fact that reduction
of the velopharyngeal space by the fat injection allows
compensatory mechanisms (contraction of the lateral pha-
ryngeal wall) that were impossible before the intervention.
Conclusion
Autologous fat injection allows a build up of a “neo-Passa-
vant’s pad” that improves hypernasal speech in patients
with mild velopharyngeal insuYciency or after a subopti-
mal velopharyngoplasty. Our study shows satisfactory per-
ceptual improvement of nasality, and acoustic nasometry
demonstrates a signiWcant decrease in the postoperative
nasalance after this intervention. The procedure is simple,
minimally invasive and can be performed as an outpatient
procedure with only minor discomfort regarding the donor
and operative sites. The ideal patient seems to be one who
has mild but continuous air emission during phonation
without articulatory diYculties. It is especially eYcient in
young patients after cleft palate repairs and can be proposed
for velocardiofacial patients. The choice of autologous fat
as the graft tissue is based on the fact that it is easily obtain-
able, inexpensive and causes no immunologic or foreign-
body reaction. Furthermore, unlike teXon, it will not
migrate or cause uncontrollable granulomas. Usually, two
injections are necessary to obtain an optimal result. InsuY-
cient results or an eventual failure of the procedure does not
preclude later corrective intervention, such as a velopharyn-
goplasty. The long-term outcome of the results and the
resorption of the autologous fat must be further evaluated.
ConXict of interest statement None.
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